TrialJournal of patient-reported outcomes2023

Psychometric validation of the Pyruvate Kinase Deficiency Diary and Pyruvate Kinase Deficiency Impact Assessment in adults in the phase 3 ACTIVATE trial.

David A Andrae et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.